205 related articles for article (PubMed ID: 35571123)
1. Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme.
Zhang X; Jin S; Shi X; Liu S; Li K; Liu G; Zhong S; Liu T; Li L; Tao S; Zhai Q; Bao N; Ren L; Wu Y; Bao Y
Front Pharmacol; 2022; 13():898679. PubMed ID: 35571123
[TBL] [Abstract][Full Text] [Related]
2. Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma.
Zhu X; Zhou Y; Ou Y; Cheng Z; Han D; Chu Z; Pan S
Aging (Albany NY); 2021 Jul; 13(13):17655-17672. PubMed ID: 34244461
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis-Related Gene Contributes to Immunity, Stemness and Predicts Prognosis in Glioblastoma Multiforme.
Dong J; Zhao H; Wang F; Jin J; Ji H; Yan X; Wang N; Zhang J; Hu S
Front Neurol; 2022; 13():829926. PubMed ID: 35359663
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis related genes are regulated by methylation and predict the prognosis of glioblastoma patients.
Zhong H; Wang Y; Jia J; Yang H; Zhang H; Li T; Liu H; Wang Y
Transl Cancer Res; 2022 Apr; 11(4):603-614. PubMed ID: 35571655
[TBL] [Abstract][Full Text] [Related]
5. Identification of SSBP1 as a ferroptosis-related biomarker of glioblastoma based on a novel mitochondria-related gene risk model and in vitro experiments.
Su J; Li Y; Liu Q; Peng G; Qin C; Li Y
J Transl Med; 2022 Sep; 20(1):440. PubMed ID: 36180956
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma.
Yan X; Ji H; Liu Z; Ma S; Dong J; Jiang X; Hu X; Wang F; Zhao H; Jin J; Zhang J; Wang N; Du J; Hu S
Front Genet; 2022; 13():880864. PubMed ID: 35559020
[No Abstract] [Full Text] [Related]
7. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y
Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis Suppressive Genes Correlate with Immunosuppression in Glioblastoma.
Deng S; Zheng Y; Mo Y; Xu X; Li Y; Zhang Y; Liu J; Chen J; Tian Y; Ke Y
World Neurosurg; 2021 Aug; 152():e436-e448. PubMed ID: 34062295
[TBL] [Abstract][Full Text] [Related]
9. A Ferroptosis-Related Prognostic Risk Score Model to Predict Clinical Significance and Immunogenic Characteristics in Glioblastoma Multiforme.
Xiao D; Zhou Y; Wang X; Zhao H; Nie C; Jiang X
Oxid Med Cell Longev; 2021; 2021():9107857. PubMed ID: 34804371
[TBL] [Abstract][Full Text] [Related]
10. Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme.
Liu E; Li W; Jian LP; Yin S; Yang S; Zhao H; Huang W; Zhang Y; Zhou H
Transl Oncol; 2023 Oct; 36():101739. PubMed ID: 37544033
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-related local immune cytolytic activity in tumor microenvironment of basal cell and squamous cell carcinoma.
Wang J; Xie D; Wu H; Li Y; Wan C
Aging (Albany NY); 2022 May; 14(9):3956-3972. PubMed ID: 35501667
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.
Huang Y; Xie Z; Li X; Chen W; He Y; Wu S; Li X; Hou B; Sun J; Wang S; He Y; Jiang H; Lun Y; Zhang J
Int Immunopharmacol; 2021 Dec; 101(Pt A):108156. PubMed ID: 34624650
[TBL] [Abstract][Full Text] [Related]
14. Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma.
Song L; Wu J; Fu H; Wu C; Tong X; Zhang M
Front Pharmacol; 2022; 13():921963. PubMed ID: 35754466
[TBL] [Abstract][Full Text] [Related]
15. Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma.
Wang X; Zhang H; Zhang M; Zhang X; Mao W; Gao M
BMC Cancer; 2023 May; 23(1):415. PubMed ID: 37158834
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
Lei T; Qian H; Lei P; Hu Y
Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
[TBL] [Abstract][Full Text] [Related]
17. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Prediction Model for Glioblastoma: A Ferroptosis-Related Gene Prediction Model and Independent External Validation.
Chen W; Lei C; Wang Y; Guo D; Zhang S; Wang X; Zhang Z; Wang Y; Ma W
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835877
[TBL] [Abstract][Full Text] [Related]
19. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
20. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma.
Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G
Front Immunol; 2021; 12():706936. PubMed ID: 34899682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
